HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marcos R M Fontes Selected Research

Peptides (Polypeptides)

3/2006Bothrops moojeni myotoxin-II, a Lys49-phospholipase A2 homologue: an example of function versatility of snake venom proteins.
3/2004Analysis of Bothrops jararacussu venomous gland transcriptome focusing on structural and functional aspects: I--gene expression profile of highly expressed phospholipases A2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marcos R M Fontes Research Topics

Disease

16Snake Bites (Snake Bite)
03/2023 - 09/2005
10Myotoxicity
08/2021 - 12/2007
6Necrosis
12/2020 - 03/2004
5Hemorrhage
12/2020 - 03/2004
5Edema (Dropsy)
03/2011 - 08/2002
4Neoplasms (Cancer)
01/2019 - 03/2006
3Pain (Aches)
12/2020 - 03/2004
2Paralysis (Palsy)
03/2023 - 11/2017
2Inflammation (Inflammations)
01/2022 - 12/2017
2Cardiotoxicity
02/2011 - 06/2010
1Ischemia
12/2020
1Blister (Bulla)
12/2020
1Rupture
03/2020
1Leishmaniasis
07/2019
1Acquired Immunodeficiency Syndrome (AIDS)
01/2019
1Colonic Neoplasms (Colon Cancer)
03/2018
1Neurodegenerative Diseases (Neurodegenerative Disease)
12/2017
1Xeroderma Pigmentosum (Kaposi's Disease)
01/2016
1Cockayne Syndrome (Syndrome, Cockayne)
01/2016
1Wounds and Injuries (Trauma)
01/2015
1Malaria
08/2010
1Nervous System Diseases (Neurological Disorders)
08/2008
1Renal Insufficiency (Renal Failure)
08/2008
1Adenocarcinoma
03/2006
1Leukemia
03/2006

Drug/Important Bio-Agent (IBA)

10Antivenins (Antivenoms)IBA
01/2022 - 02/2011
10Proteins (Proteins, Gene)FDA Link
12/2020 - 03/2004
8Snake Venoms (Snake Venom)IBA
01/2021 - 03/2004
7VenomsIBA
12/2017 - 09/2005
6Phospholipases A2 (Phospholipase A2)IBA
11/2017 - 09/2005
3Metalloproteases (Metalloproteinases)IBA
01/2022 - 07/2007
3EnzymesIBA
12/2020 - 03/2004
3Phospholipases (Phospholipase)IBA
12/2017 - 01/2017
3CrotoxinIBA
11/2017 - 08/2008
2bothropstoxinIBA
03/2023 - 09/2005
2Complement System Proteins (Complement)IBA
03/2020 - 01/2019
2Phospholipids (Phosphatides)FDA LinkGeneric
12/2017 - 02/2011
2ZincIBA
01/2017 - 07/2007
2IonsIBA
01/2017 - 12/2007
2Phospholipases AIBA
03/2011 - 02/2011
2Peptides (Polypeptides)IBA
03/2006 - 03/2004
1Single-Domain AntibodiesIBA
01/2022
1Interleukin-10 (Interleukin 10)IBA
01/2022
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022
1C-Type Lectins (C-Type Lectin)IBA
01/2022
1InterleukinsIBA
01/2022
1InflammasomesIBA
01/2022
1Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2022
1Gallic AcidIBA
08/2021
1NeurotoxinsIBA
08/2021
1PhytochemicalsIBA
08/2021
1caftaric acidIBA
03/2020
1Nuclear Localization Signals (Nuclear Localization Signal)IBA
01/2019
1Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA
01/2019
1SERPIN-B5 (maspin)IBA
01/2019
1AcidsIBA
11/2017
1Acetylcholine (Acetylcholine Chloride)FDA Link
11/2017
1QuinolonesIBA
02/2016
1piratoxin IIBA
01/2015
1caffeic acidIBA
02/2011
1protoporphyrin IXIBA
08/2010
1hemozoinIBA
08/2010
1Heme (Haem)IBA
08/2010
1Analgesics (Analgesic Drugs)IBA
06/2010
1Caseins (Casein)FDA Link
12/2007
1GelatinIBA
12/2007
1FibrinIBA
12/2007
1Fibrinogen (Factor I)FDA Link
12/2007
1CollagenIBA
12/2007
1Antiparasitic Agents (Antiparasitics)IBA
03/2006
1bothropstoxin IIIBA
09/2005
1Protein Isoforms (Isoforms)IBA
09/2005
1Indomethacin (Indometacin)FDA LinkGeneric
05/2004
1Dexamethasone (Maxidex)FDA LinkGeneric
05/2004
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
05/2004
1Edetic Acid (EDTA)FDA Link
08/2002

Therapy/Procedure

6Therapeutics
03/2020 - 02/2011
4Traditional Medicine (Folk Remedies)
03/2023 - 09/2005
1Surgical Amputation (Amputations)
12/2020
1Analgesia
12/2017